Ganciclovir Capsules

Free

Ganciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections

Categories: , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Ganciclovir Capsules

Healthy Inc is a specialized global supplier and exporter of advanced virology, immunology, and transplant-medicine therapeutics. We provide ultra-high-purity Ganciclovir Capsules (250 mg / 500 mg), manufactured in WHO–GMP certified, dedicated negative-pressure hazardous drug containment facilities. This “Nucleoside Analogue Antiviral” is a high-value, critical-care export to organ transplant centers, infectious disease wards, HIV/AIDS clinics, and government health ministries in LATAM, the Middle East, Southeast Asia, and Africa, serving as the definitive, life-saving intervention for Cytomegalovirus (CMV) retinitis and systemic CMV prophylaxis.


Product Overview

This formulation contains Ganciclovir, a synthetic guanine derivative that acts as an aggressive, highly targeted viral DNA polymerase inhibitor.

The “CMV Eradication & Transplant Defense” Specialist:

  • Mechanism (Viral DNA Termination): Ganciclovir is a prodrug that requires activation inside the infected cell. It is first phosphorylated by a specific viral enzyme (CMV UL97 kinase), and then further phosphorylated by human cellular kinases into its active form: ganciclovir triphosphate. This active molecule physically impersonates a DNA building block. When the virus attempts to use it to copy its genetic code, it competitively inhibits the viral DNA polymerase enzyme and completely halts the elongation of the viral DNA chain, stopping the infection in its tracks.
  • The Organ Transplant Shield: Patients receiving solid organ transplants (kidney, liver, heart) or bone marrow transplants must take massive doses of immunosuppressants to prevent organ rejection. This leaves them entirely defenseless against latent CMV, which can rapidly destroy the new organ or cause fatal pneumonia. Ganciclovir is the globally mandated prophylactic shield used to keep these patients alive during the highest-risk post-operative windows.
  • The HIV/AIDS Vision Protector: In patients with advanced HIV/AIDS, CMV frequently attacks the retina, causing irreversible blindness (CMV retinitis). Oral Ganciclovir is utilized as essential maintenance therapy to permanently suppress the virus and preserve the patient’s sight.

Product Composition & Strength

We supply this product as a Hard Gelatin Capsule, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing.

Active IngredientStrengthPrimary Clinical Use
Ganciclovir USP/BP/Ph.Eur.250 mgStandard pediatric dosing and dose titration for renal impairment.
Ganciclovir USP/BP/Ph.Eur.500 mgStandard Adult Dose for CMV retinitis maintenance and transplant prophylaxis.
ExcipientsCroscarmellose Sodium / Magnesium Stearate / Microcrystalline CelluloseSuperdisintegrant / Lubricant / Diluent (Ensures rapid, uniform gastric absorption)

*Pack Sizes: HDPE Bottles of 84 or 100 capsules / Alu-Alu Blisters (Optimized for strict, high-volume daily adherence regimens).


Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease NGOs, and Transplant Networks.

HS Code3004.90.99 (Medicaments containing other active substances – Antivirals)
CAS Number82410-32-0
Dosage FormHard Gelatin Capsule
PackagingHigh-Barrier Alu-Alu Blisters or HDPE Bottles. Required for API stability and to provide a sturdy, tamper-evident barrier for this cytotoxic agent.
StorageStore strictly below 25°C in a dry place. Protect from Light and Moisture. Keep out of reach of children.
CertificatesWHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • Hazardous Drug (OEB) Containment: Ganciclovir is classified as a hazardous, cytotoxic drug due to its mutagenic and teratogenic properties. Our manufacturing is executed within strictly isolated, completely dedicated blocks operating under severe negative pressure with multi-stage HEPA filtration. Powders are handled inside closed-loop barrier isolators to guarantee absolute operator safety and zero cross-contamination.
  • Dissolution Integrity: Because oral Ganciclovir has naturally poor bioavailability (around 5-9%), our formulation utilizes specialized superdisintegrants to ensure maximum possible release and absorption within the precise window of the upper GI tract, preventing sub-therapeutic clinical failures.

Therapeutic Indications (Human Use)

Indicated for the comprehensive management of severe viral infections in immunocompromised populations:

  • CMV Retinitis Maintenance: Maintenance therapy for Cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS).
  • CMV Disease Prophylaxis: Prevention of CMV disease in solid organ transplant recipients and individuals with advanced HIV infection at risk for developing CMV disease.

Dosage & Administration

Recommended Dosage (Strictly as per Transplant or Infectious Disease Specialist):

  • Administration (FOOD REQUIREMENT IS CRITICAL): Oral Ganciclovir MUST be taken with food. Taking it with a meal increases its absorption and systemic bioavailability by up to 25%, which is absolutely essential for achieving therapeutic antiviral blood levels.
  • Handling Precautions (HAZARD WARNING): Capsules MUST NOT be opened, broken, or chewed. Ganciclovir is considered a potential human carcinogen and teratogen. Healthcare providers and caregivers must wear gloves when handling the capsules or blister packs. If powder makes contact with the skin, wash the area immediately and thoroughly with soap and water.
  • Renal Adjustment: Because Ganciclovir is excreted almost entirely by the kidneys, the dose must be heavily reduced in patients with renal impairment to prevent fatal toxicity.

Safety Warnings (CRITICAL):

  • BLACK BOX WARNING (Hematologic Toxicity): Ganciclovir causes severe, life-threatening myelosuppression. It frequently induces profound granulocytopenia (loss of white blood cells), anemia, and thrombocytopenia (loss of platelets). Complete blood counts (CBC) must be monitored continuously. The drug must be interrupted if absolute neutrophil counts drop to dangerous levels.
  • BLACK BOX WARNING (Teratogenicity & Mutagenicity): Animal studies demonstrate that Ganciclovir causes catastrophic birth defects and fetal death. It also causes temporary or permanent inhibition of spermatogenesis in males. It is strictly contraindicated in pregnancy. Females and males of reproductive potential must use highly effective contraception during therapy and for at least 90 days following the final dose.
  • BLACK BOX WARNING (Carcinogenicity): Ganciclovir has been shown to be carcinogenic in animal models. It should be handled and prescribed with the exact same caution as chemotherapy drugs.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antiviral and Transplant Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable NGO Tender Supplier for HIV/AIDS programs in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Specialty Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Reviews

There are no reviews yet.

Be the first to review “Ganciclovir Capsules”

Your email address will not be published. Required fields are marked *